Predictors of Local Recurrence in High-grade Soft Tissue Sarcomas: Hydrogen Peroxide as a Local Adjuvant
|
|
- Cody Barry Perkins
- 5 years ago
- Views:
Transcription
1 Predictors of Local Recurrence in High-grade Soft Tissue Sarcomas: Hydrogen Peroxide as a Local Adjuvant Adam N. Wooldridge, MD, MPH; Gregory P. Kolovich, MD, MPH; Martha K. Crist, RN; Joel L. Mayerson, MD; Thomas J. Scharschmidt, MD abstract Full article available online at Healio.com/Orthopedics. Search: Soft tissue sarcomas have a mortality rate of 40% to 60%, with local recurrence being a poor prognostic factor for overall survival. Three-percent nondiluted hydrogen peroxide is hypothesized to be an effective local adjuvant. The purpose of this study was to identify risk factors for local recurrence in high-grade soft tissue sarcomas and to determine whether using hydrogen peroxide as a local adjuvant reduced the risks of local recurrence and surgical-site infection. Retrospective data were collected for 106 patients surgically treated for high-grade soft tissue sarcomas between 2002 and The primary endpoint was local recurrence. Eighteen (16.98%) cases of local recurrence occurred. Predictors of local recurrence were margin status, estimated blood loss, and histology (ie, malignant peripheral nerve sheath tumor), with hazard ratios of 4.44 (95% confidence interval [CI], ), 1.19 (95% CI, ), and 9.21 (95% CI, ), respectively. Hydrogen peroxide yielded a statistically insignificant improvement in local recurrence, with a hazard ratio of 0.81 (95% CI, ) and a reduced risk of surgical site infection, with a hazard ratio of 0.52 (95% CI, ). Margin status, increased blood loss, and histologic subtype are associated with increased local recurrence risk. Using hydrogen peroxide improved local control and infection rates, but the difference was not statistically significant. The authors are from the Department of Orthopaedic Surgery and Rehabilitation (ANW), Texas Tech University Health Sciences Center, Lubbock, Texas; and the Department of Orthopaedics (GPK, MKC, JLM, TJS), The Ohio State University, Columbus, Ohio. The authors have no relevant financial relationships to disclose. This study was performed at Wexner Medical Center, The Ohio State University, Columbus, Ohio. Correspondence should be addressed to: Thomas J. Scharschmidt, MD, Division of Musculoskeletal Oncology, College of Medicine, Department of Orthopedics, The Ohio State University, 725 Prior Hall, Columbus, OH (thomas.scharschmidt@osumc.edu). doi: / e207
2 Soft tissue sarcomas are rare entities of mesenchymal origin with mortality rates of 40% to 60%. 1 In the United States in 2011, an estimated 10,980 cases of soft tissues sarcoma with an estimated 3920 deaths occurred. 2 Overall mortality is negatively affected by local recurrence. 3-6 Improvements in local control are important because local recurrence rates have been reported at 13% to 27%. 7-9 Previous studies have reported age, margin status, grade, and histology as local recurrence predictors. 3,9-10 Margin status is consistently associated with a risk of local recurrence. The application of a tumoricidal agent as a local adjuvant to the tumor bed has been hypothesized to decrease local recurrence rates. 11 In vitro studies demonstrated cytotoxic activity of hydrogen peroxide in brain 12 and breast 13 cancer. Retrospective reviews of hydrogen peroxide as a local adjuvant for giant cell tumor of bone have been effective To the current authors knowledge, no studies have reported using hydrogen peroxide as a local adjuvant in the treatment of soft tissue sarcomas. Due to the rarity of soft tissue sarcomas, ascertaining which factors improve local control is difficult. Radiation, used neoadjuvantly or adjuvantly, has reduced the local recurrence rate; however, it is associated with complications, such as infection, edema, and fibrosis. The increased usage of limb-salvage surgery instead of amputation has made local control more important. Therefore, the authors examined (1) whether additional patient and tumor variables (ie, age, tumor size, depth, location, and blood loss) affected the risk of local recurrence, and (2) whether using hydrogen peroxide as a local adjuvant reduced the local recurrence risk. In addition, the authors assessed whether using hydrogen peroxide was associated with a reduced surgicalsite infection risk. Materials and Methods This retrospective evaluation was approved by the institutional review board (protocol #2010C0011). Data were collected for 127 patients evaluated and treated by a single surgeon (T.J.S.) for high-grade soft tissue sarcoma between 2002 and One hundred six patients were included in the final analysis. Ten patients were excluded due to presentation with local recurrence and 11 patients were excluded due to inability to ascertain pre- and postoperative radiation and chemotherapy information from the medical records. All tumors in the analysis were deep (relative to the investing fascia) and high grade. Patient demographics and tumor characteristics were collected from a retrospective review. Patient characteristics included age, sex, and race. Tumor data collected included size in centimeters (for the largest diameter), location (ie, upper extremity, central, or proximal lower and distal lower extremity), and histopathology. Histological subtypes included malignant fibrous histiocytoma, leiomyosarcoma, liposarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumor. Prognostic factors (ie, death, distant metastasis, and local recurrence) and the time frames in which they occurred were collected. Additional clinical factors collected were the use of pre- or postoperative chemotherapy and radiotherapy, presence of comorbid diseases (eg, diabetes mellitus and immune disorders), history of previous infections, operative time (minutes), incision size (cm), estimated blood loss (per 100-mL increase), transfusion requirement, whether resection occurred at another institution, use of hydrogen peroxide as a local adjuvant, surgical-site infections (as defined by the Centers for Disease Control), 17 and time to infection. Descriptive data are listed in Table 1. Use of hydrogen peroxide as a local adjuvant was confirmed in 79 (74.5%) of 106 patients. Median age at diagnosis was 57.5 years, and 53.8% of patients were women. Median excised tumor size was 7.25 cm, and the most common location was the proximal lower extremity (47.2%). Twelve (11.3%) instances occurred of close/positive margins, and the most common histologic subtype was malignant fibrous histiocytoma (55 [51.9%] patients). Local recurrence occurred in 18 (16.98%) patients, with a median time to local recurrence of 27 months. Moreover, 11 (10.3%) patients acquired a surgicalsite infection, whereas 10 (9.4%) patients had a wound complication (eg, wound breakdown or flap necrosis). Demographic and clinical variables were summarized and compared using Wilcoxon rank sum, chi-square, or Fisher s exact tests. Descriptive summaries of continuous variables were presented in terms of interquartile range, whereas discrete variables were summarized in terms of frequencies and percentages. Hazard ratios and 95% confidence intervals (CIs) for local recurrence were estimated with univariable and multivariable Cox proportional hazards models. 18 The multivariable model was estimated using stepwise hierarchical backward selection. The proportional hazards assumption was assessed by testing the interaction of follow-up time and testing of Schoenfeld residuals. No significant deviations occurred from the proportional hazards assumption. Analyses were conducted with Stata version 12 software (StataCorp, College State, Texas). Statistical tests were 2-sided, and a P value less than.05 indicated statistical significance. Results During follow-up (average follow-up, 7.13 years), 18 (16.98%) cases of local recurrence occurred. Although hydrogen peroxide appeared to lengthen the time to local recurrence compared with not using hydrogen peroxide (27 vs 24.2 months, respectively), the difference was not statistically significant (P5.915). The overall probability of local recurrence during follow-up is shown in Figure 1. Of the 16 variables considered in univariable analye208 ORTHOPEDICS Healio.com/Orthopedics
3 Hydrogen Peroxide in Soft Tissue Sarcomas Wooldridge et al Table 1 Patient Demographics and Tumor Characteristics Receiving Hydrogen Peroxide Variable Factor Yes (n579) No (n527) P Total (N=106) Median age (IQR), y 57 (46-70) 59 (33-73).630 a 57.5 (45-70) Sex, No. (%) Male 37 (46.8) 12 (44.4) 49 (46.2).830 b Female 42 (53.2) 15 (55.5) 57 (53.8) Race, No. (%) White 71 (89.9) 25 (92.6) 96 (90.6).99 c Other 8 (10.1) 2 (7.41) 10 (9.43) Median size (IQR), cm 7 (4.5-12) 7.5 ( ).674 a 7.25 (4.8-12) Location, No. (%) d Upper extremity 13 (16.5) 3 (11.1) 16 (15.1) Central 11 (13.9) 4 (14.8) 15 (14.2).030 c Proximal lower extremity 42 (53.2) 8 (29.6) 50 (47.2) Distal lower extremity 12 (15.2) 13 (48.2) 25 (23.6) Microscopic margin, No. (%) Negative 70 (88.6) 24 (88.9) 94 (88.7).637 c Positive 9 (11.4) 3 (11.1) 12 (11.3) Histology, No. (%) MFH 41 (51.9) 14 (51.9) 55 (51.9) Leiomyosarcoma 16 (20.3) 4 (14.8) 20 (18.9) Liposarcoma 8 (10.1) 2 (7.41).886 c 10 (9.43) Synovial sarcoma 7 (8.86) 3 (11.1) 10 (9.43) MPNST 7 (8.86) 4 (14.8) 11 (10.4) Presents with metastasis, No. (%) Yes 6 (7.59) 3 (11.1) 9 (8.49).690 c No 73 (92.4) 24 (88.9) 97 (91.5) Radiation therapy, No. (%) d No 16 (20.3) 15 (55.6) (29.2) Preoperative 1 (1.27) 1 (3.70).446 c 2 (1.89) Postoperative 63 (79.7) 11 (40.7) <.05 c 74 (69.8) Chemotherapy, No. (%) No 45 (56.96) 16 (59.3) (57.5) Preoperative 24 (30.4) 7 (25.9) (29.2) Postoperative 29 (36.7) 7 (25.9) (33.96) Excision at another hospital, No. (%) Yes 24 (34.2) 4 (5.06) 28 (26.4).135 c No 55 (69.6) 23 (85.2) 78 (73.6) Surgical type, No. (%) d Limb salvage 76 (96.2) 14 (51.8) 90 (84.9),.05 c Amputation 3 (3.80) 13 (48.1) 16 (15.1) Median follow-up, No. (IQR), mo d 31.6 ( ) 21.0 ( ).040 a 27.2 ( ) Survival status, No. (%) Alive 51 (64.6) 19 (70.4) 70 (66.0).644 c Deceased 28 (35.4) 8 (29.6) 36 (33.96) Median time to death (IQR), mo 21.2 ( ) 17 ( ).424 a 18.9 ( ) Local recurrence, No. (%) Yes 14 (17.7) 4 (14.8) 18 (17.0).99 c No 65 (82.3) 23 (85.2) 88 (83.0) Median time to local recurrence (IQR), mo 27 ( ) 24.2 ( ).915 a 27 ( ) Distant metastasis, No. (%) Yes 26 (32.9) 11 (40.7) 37 (34.9).490 c No 53 (67.1) 16 (59.3) 69 (65.1) Median time to metastasis (IQR) 12.4 ( ) 11.2 ( ).947 a 12.2 ( ) Abbreviations: IQR, interquartile range; MFH, malignant fibrous histiocytoma; MPNST, maligtnant peripheral nerve sheath tumor. a Wilcoxon rank sum test. b Chi-square test. c Fisher s exact test. d P values less than.05 indicate differences in proportion of hydrogen peroxide use for location, surgical type, and radiation therapy. e209
4 sis, margin status, postoperative metastasis, estimated blood loss, and histologic subtype were associated with a higher local recurrence risk (Figure 2; Table 2). Stepwise backward hierarchical selection yielded 3 predictors of local recurrence: margin status, estimated blood loss, and histology (Figure 3; Table 3). During follow-up, the risk of local recurrence among those with close or positive margins was 4.44 (95% CI, ) times those with negative margins. The risk of local recurrence for a 100-mL increase in estimated blood loss was 1.19 (95% CI, ) times those with no change in estimated blood loss. During the 7-year follow-up, the instantaneous risk of local recurrence among those with a malignant peripheral nerve sheath tumor was 9.21 (95% CI, ) times those with a malignant fibrous histiocytoma. Local recurrence probabilities for the follow-up period adjusted for margin status, estimated blood loss, and histology are shown in Figure 3. No difference existed in the probability of local recurrence between the hydrogen peroxide and no hydrogen peroxide groups (P5.712) (Figure 4). Regarding the authors secondary focus, 11 (10.4%) surgical-site infections occurred. The proportion of patients with surgical-site infections was smaller in the hydrogen peroxide group than the no hydrogen peroxide group (8.86% vs 14.8%, respectively), but the difference did not reach statistical significance (P5.466) (Table 3). In the univariable and multivariable analyses, only age was associated with an increased surgicalsite infection risk (Table 4). During follow-up, a 10-year increase in age correlated with a 1.56-times higher (95% CI, ) risk of local recurrence. Although statistically insignificant, the surgical-site infection risk among patients receiving hydrogen peroxide as a local adjuvant was 0.52 (95% CI, ) times higher than those receiving no local adjuvant. No association existed between operative time (hazard ratio 1.00; 95% CI, ) or incision size (hazard ratio 1.00; 95% CI, ). Although wellestablished risk factors for infection (eg, comorbid disease, previous infections, and postoperative wound complications) were associated with an increased surgicalsite infection risk, they did not reach statistical significance. Discussion Due to the strong association between local recurrence and sarcoma-related death, a better understanding of prognostic factors and how to improve local control is needed. Therefore, the authors determined which prognostic factors influence local recurrence and whether using hydrogen peroxide as 2A 2C 1 a local adjuvant reduces the risk of local recurrence and surgical-site infection. The current study had limitations. Because the sample included 106 patients with 18 local recurrences, the maximum number of predictors for a multivariable model was limited. Therefore, the probability of an increase in type II error was considerable. Hazard ratios could not be Figure 1: Kaplan-Meier curve for local recurrence without adjustment showing that the overall probability of local recurrence was 56.7% (95% confidence interval, 34.1%-74.2%) by the end of follow-up. Y-axis: survival rate. Figure 2: Kaplan-Meier curves comparing local recurrence in positive vs negative margins (A), for different histologies (B), for estimated blood loss (C), and for postoperative metastasis (D). Of the 16 variables included in univariable analysis, 4 were associated with a higher local recurrence risk: positive margins (A), histology (B), estimated blood loss (C), and postoperative metastasis (D). Y-axis: survival rate. Abbreviations: Mets, metastases; MFH, malignant fibrous histiocytoma; MPNST, malignant peripheral nerve sheath tumor; Post-op, postoperative. 2B 2D e210 ORTHOPEDICS Healio.com/Orthopedics
5 Hydrogen Peroxide in Soft Tissue Sarcomas Wooldridge et al Table 2 Secondary Outcome: Surgical-site Infection Receiving Hydrogen Peroxide Variable Yes (n579) No (n527) P Total (N5106) Infection, No. (%) Yes 7 (8.86) 4 (14.8) 11 (10.3) No 72 (91.1) 23 (85.2) 95 (89.7) Median time to infection (IQR), d 29 (14-106) 23.5 ( ).571 b 28 (14-76) Comorbid disease, No. (%) Diabetes mellitus 10 (12.6) 2 (7.41) 12 (11.3) Autoimmune disorder 6 (7.59) 3 (11.1) 9 (8.49) Median BMI (IQR), kg/m 2c 28 (24-33) 25.5 (22-29).0082 b 27 (24-32) Smoking, No. (%) Yes 12 (15.2) 4 (5.06) 16 (15.1) No 67 (84.8) 23 (85.2) 90 (84.9) Median surgery time (IQR), min 121 (78-205) 139 (81-194).612 b (80-194) Median incision size (IQR), cm c 16 (10-20) 25 (12-40).015 b 17 (12-25) Median EBL (IQR), ml 150 ( ) 100 ( ).795 b 150 ( ) Transfusion, No. (%) Yes 19 (24.1) 5 (18.5) 24 (25.4) No 60 (75.9) 22 (81.5) 82 (77.4) Wound complications, No. (%) Delayed healing 5 (6.33) 2 (7.41) 7 (6.60) Flap necrosis 2 (2.53) 1 (3.70) 3 (2.83) History of infection, No. (%) Yes 3 (3.79) 0 (0) 3 (2.83) No 76 (96.2) 27 (100) 103 (97.2) Abbreviations: BMI, body mass index; EBL, estimated blood loss; IQR, interquartile range. a Fisher s exact test. b Wilcoxon rank sum test. c P values less than.05 indicate differences in proportion of hydrogen for incision size..466 a.711 a.99 a.790 a.217 a.569 a 3 Figure 3: Adjusted Kaplan-Meier curve controlling for the variables of margin status, estimated blood loss, and histology. Y-axis: survival rate. reported for liposarcoma and synovial sarcoma due to the small sample size. Given the retrospective nature of the study, a high probability exists of selection bias with well-defined inclusion and exclusion criteria. Factors not included in the analysis were time to chemotherapy and radiotherapy or types of chemotherapy and radiation doses. Amputations and proximity to neurovascular structures were typically associated with no hydrogen peroxide in the current cohort. However, the authors could not definitely note these scenarios from the medical record without introducing recall bias. Inability to control these factors increases type II error and biases the result to the null hypothesis. Nonetheless, this is a relatively large series focusing specifically on outcomes in high-grade soft tissue sarcomas. In the current report, margin status, estimated blood loss, and histologic sub- e211
6 Table 3 Predictors of Local Recurrence Variable Univariable P HR (95% CI) Multivariable P HR (95% CI) 10-y age increase ( ) Sex ( ) Race a Size (per 1-cm increase) ( ) Margin ( ) ( ) Location Pelvic vs upper extremity ( ) Upper leg vs upper extremity ( ) Lower leg vs upper extremity ( ) Resection at another hospital ( ) Radiation Preop ( ) Postop ( ) Chemotherapy Preop (0.40, 2.90) Postop ( ) Mets At presentation ( ) Postop < ( ) Peroxide ( ) Amputation ( ) BMI ( ) 100-mL EBL increase ( ) ( ) Transfusion ( ) Histology Leiomyosarcoma vs MFH ( ) Liposarcoma vs MFH a Synovial vs MFH a MPNST vs MFH ( ) ( ) Abbreviations: BMI, body mass index; CI, confidence interval; EBL, estimated blood loss; HR, hazard ratio; mets, metastases; MFH, malignant fibrous histiocytoma; MPNST, malignant peripheral nerve sheath tumor. a An insufficient number of events occurred to calculate hazard ratios. type were predictors of local recurrence. Previous studies have reported correlations between margin status and histologic subtypes. 3,9-10,19-22 Controlling margin status is critical in preventing local recurrence. The hazard ratios observed in the current analysis are similar to those reported in the literature. 9,23 In the creation of a nomogram for the local recurrence risk reported by Cahlon et al, 9 a review of 684 patients with primary, nonmetastatic disease yielded an estimated hazard ratio of 2.37 (95% CI, ) for positive/ close margins. In a review of 278 patients comparing primary vs re-excision by Alamanda et al, 23 positive margins yielded an estimated hazard ratio of 3.76 (95% CI, ). Difficult resections near neurovascular structures increase the likelihood of close margins. Although radiotherapy can improve local control, 24 treatments are often delayed due to poor wound healing. Intraoperative local adjuvants pro- e212 ORTHOPEDICS Healio.com/Orthopedics
7 Hydrogen Peroxide in Soft Tissue Sarcomas Wooldridge et al 4 Figure 4: Graph showing the local recurrence curve for hydrogen peroxide. No statistically significant relationship existed in local recurrence between patients treated with (solid line) and without (dotted line) hydrogen peroxide. Y-axis: survival rate. vide an opportunity to improve local control. Hydrogen peroxide has been used as a local adjuvant in the control of giant cell tumor of bone Using hydrogen peroxide as a local adjuvant did not change the proportion of patients with local recurrence compared with patients receiving no local adjuvant (17.7% vs 14.8%, respectively; P5.99). Although the median time to local recurrence was longer in the hydrogen peroxide group than the no hydrogen peroxide group (27 vs 24.2 months, respectively), the difference was not statistically significant (P5.915). The hazard ratio for local recurrence with hydrogen peroxide as a local adjuvant during follow-up was 0.81 (95% CI, ). Due to the limited number of local recurrences (n54) in the pa- Table 4 Factors Predictive of Surgical-site Infection Variable Univariable P HR (95% CI) Multivariable P HR (95% CI) 10-y age increase (1.04 to 2.35) ( ) Sex (0.12 to 1.70) Race (21.84 to 2.30) Size (per 1-cm increase) (0.92 to 1.12) Margin (0.10 to 6.11) Location Pelvic vs upper extremity (0.08 to 19.55) Upper leg vs upper extremity (0.24 to 16.66) Lower leg vs upper extremity (0.21 to 19.42) Radiation a Preoperative Postoperative (0.09 to 0.99) Chemotherapy Preoperative (0.10 to 2.27) Postoperative (0.09 to 1.98) Operative time (0.9 to 1.01) Incision size (0.96 to 1.05) Amputation (0.29 to 6.24) Body mass index (0.94 to 1.15) Estimated blood loss (0.99 to 1.00) Transfusion (0.59 to 8.53) Comorbid disease Diabetes mellitus (0.39 to 8.64) Autoimmune (0.13 to 8.37) Previous infection (0.52 to 32.30) Wound quality (0.37 to 23.25) Postop wound complications a Hydrogen peroxide (0.15 to 1.81) a An insufficient number of events occurred to estimate hazard ratios. e213
8 tients who received no hydrogen peroxide (n527), conclusions cannot be drawn on the efficacy of hydrogen peroxide as a local adjuvant due to increased type II error that biases the result to the null hypothesis. Although the decreased risk of local recurrence observed with hydrogen peroxide therapy was not statistically significant, this does not preclude hydrogen peroxide as a clinically significant adjuvant. Estimated blood loss increased the risk of local recurrence. It was hypothesized that the association between estimated blood loss and local recurrence risk was due to blood transfusions. In a study on colon cancer, Amato and Pescatori 25 reported an increased risk for local recurrence if the patient received a blood transfusion. The hypothesis that blood transfusion mechanism increased the local recurrence risk is due to immunomodulation. 26 This theory is also an explanation for why local recurrence is more prominent in older patients. 27,28 For patients receiving a packed red blood cell transfusion, the local recurrence risk was 1.41 (95% CI, ) times higher than those receiving no transfusion. The association most likely did not reach statistical significance due to the sample size and collinearity with estimated blood loss. The current results are similar to those in a report of 232 patients with high-grade soft tissue sarcoma by Heslin et al 29 that reported no association between blood transfusion and local recurrence (P5.26). However, Newcomer et al 30 reported a relationship between transfusions and postoperative metastasis risk (P5.037). Several studies have determined the increased risk of local recurrence with varying histologic subtypes. In a nomogram for local recurrence, Cahlon et al 9 estimated that all histologic subtypes as compared with well-differentiated liposarcoma had 2.86 (95% CI, ) times the risk of local recurrence. Pisters et al 31 reported that fibrosarcoma had 2.5 (95% CI, ) times the risk and that malignant peripheral nerve sheath tumor had 1.8 (95% CI, ) times the risk of local recurrence. Histologic subtype and grade are vital in patient counseling and have been integrated into nomograms predicting mortality and local recurrence by the Memorial Sloan Kettering Sarcoma Registry. 32 Although hydrogen peroxide reduced the surgical-site infection risk (hazard ratio50.52) in the current study, the difference did not reach statistical significance (P5.308). Comorbid disease, previous infections, and wound quality are commonly associated with increased infection risk. Although the current results showed increased risk for these factors, they did not reach statistical significance. Due to the low incidence of surgical-site infections, a larger sample size is needed to determine whether the differences reach statistical significance. Conclusion Increased risk of local recurrence was associated with positive margin status, increased estimated blood loss, and histologic subtype (ie, malignant peripheral nerve sheath tumor), which is consistent with previous research. 3,9,10 Particular emphasis should be placed on obtaining negative margins and meticulous hemostasis to decrease local recurrence. Hydrogen peroxide reduced the risks of local recurrence and surgical-site infection, but the differences did not reach statistical significance. The authors recommend using hydrogen peroxide as a low-risk, low-cost local adjuvant. Although the current results did not reach statistical significance, hydrogen peroxide should not be ruled out as a clinically relevant local adjuvant. Further studies are needed to explore hydrogen peroxide as a local adjuvant. Appropriate validation with future randomized, controlled trials or metaanalyses is needed to determine whether hydrogen peroxide or other local adjuvants can improve local control. References 1. Gilbert NF, Cannon CP, Lin PP, Lewis VO. Soft-tissue sarcoma. J Am Acad Orthop Surg. 2009; 17(1): Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4): Eilber FC, Rosen G, Nelson SD, et al. Highgrade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003; 237(2): Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20(3): Gronchi A, Miceli R, Fiore M, et al. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol. 2007; 14(5): Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D. Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out? Clin Orthop Relat Res. 2010; 468(11): Trovik CS, Bauer HC, Alvegard TA, et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgicallytreated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer. 2000; 36(6): Karakousis CP, Proimakis C, Rao U, Velez AF, Driscoll DL. Local recurrence and survival in soft-tissue sarcomas. Ann Surg Oncol. 1996; 3(3): Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg. 2012; 255(2): Trovik CS, Bauer HC, Berlin O, et al. Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand. 2001; 72(2): Docherty JG, McGregor JR, Purdie CA, Galloway DJ, O Dwyer PJ. Efficacy of tumoricidal agents in vitro and in vivo. Br J Surg. 1995; 82(8): Mesiwala AH, Farrell L, Santiago P, Ghatan S, Silbergeld DL. The effects of hydrogen peroxide on brain and brain tumors. Surg Neurol. 2003; 59(5): Lucarotti ME, White H, Deas J, Silver IA, Leaper DJ. Antiseptic toxicity to breast carcinoma in tissue culture: an adjuvant to conservation therapy? Ann R Coll Surg Engl. 1990; 72(6): e214 ORTHOPEDICS Healio.com/Orthopedics
9 Hydrogen Peroxide in Soft Tissue Sarcomas Wooldridge et al 14. Balke M, Schremper L, Gebert C, et al. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008; 134(9): Ward WG Sr, Li G III. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res. 2002; (397): Nicholson NC, Ramp WK, Kneisl JS, Kaysinger KK. Hydrogen peroxide inhibits giant cell tumor and osteoblast metabolism in vitro. Clin Orthop Relat Res. 1998; (347): Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992; 13(10): Cox DR. Regression models and lifetables (with discussion). J R Stat Soc B Stat Methodol ; 34: Potter BK, Adams SC, Pitcher JD Jr, Temple HT. Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res. 2008; 466(12): Lewis JJ, Leung D, Heslin M, Woodruff JM, Brennan MF. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997; 15(2): Heslin MJ, Woodruff J, Brennan MF. Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: implications for management. J Clin Oncol. 1996; 14(2): Gronchi A, Lo Vullo S, Colombo C, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010; 251(3): Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE. Primary excision compared with re-excision of extremity soft tissue sarcomas is anything new? J Surg Oncol. 2012; 105(7): McGee L, Indelicato DJ, Dagan R, et al. Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity [published online ahead of print May 4, 2012]. Int J Radiat Oncol Biol Phys. 25. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006; 25(1):CD Brand A. Immunological aspects of blood transfusions. Transpl Immunol. 2002; 10(2-3): Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med. 1994; 18(4): Blumberg N, Triulzi DJ, Heal JM. Transfusion-induced immunomodulation and its clinical consequences. Transfus Med Rev. 1990; 4(4 suppl 1): Heslin MJ, Gaynor JJ, Newman E, et al. Effect of perioperative blood transfusion on recurrence and survival in 232 primary highgrade extremity sarcoma patients. Ann Surg Oncol. 1994; 1(3): Newcomer AE, Dylinski D, Rubin BP, et al. Prognosticators in thigh soft tissue sarcomas. J Surg Oncol ; 103(1): Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996; 14(5): Memorial Sloan-Kettering Cancer Center. Soft Tissue Sarcoma Prediction Tools. org/cancer-care/adult/soft-tissue-sarcoma/prection-tools. Accessed January 15, e215
Introduction ORIGINAL RESEARCH
Cancer Medicine ORIGINAL RESEARCH Open Access The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long- term community- based cancer center experience Jeffrey
More informationAuthor's response to reviews
Author's response to reviews Title: Should tumor depth be included in prognostication of soft tissue sarcoma? Minor prognostic value of tumor depth in a population-based series of 490 patients with soft
More informationWe considered whether a positive margin
Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence C. H. Gerrand, J. S. Wunder, R. A. Kandel, B. O Sullivan, C. N. Catton, R. S.
More informationPrognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk
843 Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk Tadashi Hasegawa, M.D. 1 Seiichiro Yamamoto, Ph.D. 2
More informationRadiation Therapy for Soft Tissue Sarcomas
Radiation Therapy for Soft Tissue Sarcomas Alexander R. Gottschalk, MD, PhD Assistant Professor, Radiation Oncology University of California, San Francisco 1/25/08 NCI: limb salvage vs. amputation 43 patients
More informationChapter 2 Natural History: Importance of Size, Site, and Histopathology
Chapter 2 Natural History: Importance of Size, Site, and Histopathology Natural History The natural history of soft tissue sarcoma is highly in fl uenced by the site of the primary lesion, tumor histopathology,
More informationRetroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients
Retroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients INGO ALLDINGER 1,2, QIN YANG 3, CHRISTIAN PILARSKY 1, HANS-DETLEV SAEGER 1, WOLFRAM T. KNOEFEL
More informationMultidisciplinary management of retroperitoneal sarcomas
Multidisciplinary management of retroperitoneal sarcomas Eric K. Nakakura, MD UCSF Department of Surgery UCSF Comprehensive Cancer Center San Francisco, CA 7 th Annual Clinical Cancer Update North Lake
More informationWhat s New in Radiotherapy For STS of The Extremity? Kaled M. Alektiar, MD, FASTRO Dept of Rad Onc Memorial Sloan Kettering Cancer Center
What s New in Radiotherapy For STS of The Extremity? Kaled M. Alektiar, MD, FASTRO Dept of Rad Onc Memorial Sloan Kettering Cancer Center Topics Predictive tools for risk assessment Reassessment of dose/volume
More informationSoft-tissue sarcoma of the thigh
72 Acta Orthop Scand 2001; 72 (1): 72 77 Soft-tissue sarcoma of the thigh Surgical margin influences local recurrence but not survival in 152 patients Søren Vraa, Johnny Keller, Ole Steen Nielsen, Anne
More informationJ Clin Oncol 22: by American Society of Clinical Oncology INTRODUCTION
VOLUME 22 NUMBER 22 NOVEMBER 15 2004 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Cohort Analysis of Patients With Localized, High-Risk, Extremity Soft Tissue Sarcoma Treated at Two Cancer
More informationPrognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
Rare Tumors 2013; volume 5:e55 Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients Ling Cai, 1 René-Olivier
More informationRECURRENCE PATTERNS AND SURVIVAL FOR PATIENTS WITH INTERMEDIATE- AND HIGH-GRADE MYXOFIBROSARCOMA
doi:10.1016/j.ijrobp.2010.08.042 Int. J. Radiation Oncology Biol. Phys., Vol. 82, No. 1, pp. 361 367, 2012 Copyright Ó 2012 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/$ - see front
More informationLong term survival study of de-novo metastatic breast cancers with or without primary tumor resection
Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Dr. Michael Co Division of Breast Surgery Queen Mary Hospital The University of Hong Kong Conflicts
More informationExtraskeletal osteosarcoma: analysis of outcome of a rare neoplasm
Sarcoma (2000) 4, 119± 123 ORIGINAL ARTICLE Extraskeletal osteosarcoma: analysis of outcome of a rare neoplasm MARTIN D. MCCARTER, 1 JONATHAN J. LEWIS, 1 CRISTINA R. ANTONESCU 2 & MURRAY F. BRENNAN 1 1
More informationIndeterminate Pulmonary Nodules in Patients with Colorectal Cancer
Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,
More informationUnplanned Surgical Excision of Tumors of the Foot and Ankle
The rarity of sarcomas of the foot and ankle often results in unplanned surgical resection, and further surgery is often required to achieve tumor-free margins. Adrienne Anderson. Parallax View, 1999-2000.
More informationRecurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas
ORIGINAL ARTICLE The ANNALS of AFRICAN SURGERY www.sskenya.org Recurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas Motanya JB 1, Saidi H 2 1 Molo District Hospital, Nakuru, Kenya
More informationDiagnosis and management of retroperitoneal sarcoma
SON Update 2017 Diagnosis and management of retroperitoneal sarcoma Andrea J MacNeill, MD MSc FRCSC Surgical Oncologist, BC Cancer Agency Vancouver 2 Histologic Subtypes of STS 3 RP Subtypes (n=684) Extremity
More informationShould soft tissue sarcomas be treated at a specialist centre?
Sarcoma, March 2004, VOL. 8, NO. 1, 1 6 ORIGINAL ARTICLE Should soft tissue sarcomas be treated at a specialist centre? A.A. BHANGU 1, J.A.S BEARD 1 & R.J. GRIMER 2 1 University of Birmingham Medical School,
More informationProcesses and outcomes of care for soft tissue sarcoma of the extremities
Sarcoma (2002) 6, 19 26 ORIGINAL ARTICLE Processes and outcomes of care for soft tissue sarcoma of the extremities LAWRENCE PASZAT 1,2,3, BRIAN O SULLIVAN 3, ROBERT BELL 4, VIVIEN BRAMWELL 5, PATTI GROOME
More informationScandinavian Sarcoma Group. Ass. Prof. Otte Brosjö,, Karolinska Hospital, Stockholm
Scandinavian Sarcoma Group Ass. Prof. Otte Brosjö,, Karolinska Hospital, Stockholm The Scandinavian Sarcoma Group Organisation of Care and Research Quality management - the SSG experience Multidisciplinary
More informationEVIDENCE BASED MANAGEMENT FOR SOFT TISSUE SARCOMA
EVIDENCE BASED MANAGEMENT FOR SOFT TISSUE SARCOMA A Documentation of exact extent of primary tumor Clinical examination, X-ray, MRI (MRI has become the premier imaging modality for the evaluation of musculoskeletal
More informationTemporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
More informationThe impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis
Received: 1 May 2017 Accepted: 23 May 2017 DOI: 10.1002/jso.24727 RESEARCH ARTICLE The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis
More informationPan Arab Journal of Oncology
Pan Arab Journal of Oncology Original Article Retrospective Analysis of Clinicopathologic and Management Aspects of Soft Tissue Sarcoma Tarek Hussein Kamel, Azza Mohamed Adel, Reham Mohamed Faheim, Rana
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated
More informationNatural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry
2015;112:872 876 Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry PETER L. JERNIGAN, MD, KOFFI WIMA, MS, DENNIS J. HANSEMAN, PhD, RICHARD
More informationResearch Article Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma
Sarcoma, Article ID 902620, 8 pages http://dx.doi.org/10.1155/2014/902620 Research Article Clinical Features and Outcomes Differ between and Osteosarcoma Sheila Thampi, 1 Katherine K. Matthay, 1 W. John
More informationPatterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival
1366 Original Research Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival Sujana Movva, MD a ; Margaret von Mehren, MD a ; Eric A. Ross, PhD b ; and
More informationORIGINAL ARTICLE. Adult Soft Tissue Ewing Sarcoma or Primitive Neuroectodermal Tumors
Adult Soft Tissue Ewing Sarcoma or Primitive Neuroectodermal Tumors Predictors of Survival? Robert C. G. Martin II, MD; Murray F. Brennan, MD ORIGINAL ARTICLE Background: Ewing sarcoma (ES) is the second
More informationSurgical Management of Advanced Stage Colon Cancer. Nathan Huber, MD 6/11/14
Surgical Management of Advanced Stage Colon Cancer Nathan Huber, MD 6/11/14 Colon Cancer Overview Approximately 50,000 attributable deaths per year Colorectal cancer is the 3 rd most common cause of cancer-related
More informationThe other bone sarcomas
ONCOLOGY The other bone sarcomas PROGNOSTIC FACTORS AND OUTCOMES OF SPINDLE CELL SARCOMAS OF BONE E. E. Pakos, R. J. Grimer, D. Peake, D. Spooner, S. R. Carter, R. M. Tillman, S. Abudu, L. Jeys From Royal
More informationRisk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationAfter primary tumor treatment, 30% of patients with malignant
ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant
More informationORIGINAL ARTICLE BONE AND SOFT TISSUE SARCOMAS
Ann Surg Oncol (2018) 25:776 783 https://doi.org/10.1245/s10434-017-6080-3 ORIGINAL ARTICLE BONE AND SOFT TISSUE SARCOMAS Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival
More informationThe Pennsylvania State University. The Graduate School. Department of Public Health Sciences
The Pennsylvania State University The Graduate School Department of Public Health Sciences THE LENGTH OF STAY AND READMISSIONS IN MASTECTOMY PATIENTS A Thesis in Public Health Sciences by Susie Sun 2015
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Callegaro D, Miceli R, Bonvalot S, et al. Development
More informationWe have previously reported good clinical results
J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional
More informationTransmetatarsal amputation in an at-risk diabetic population: a retrospective study
The Journal of Diabetic Foot Complications Transmetatarsal amputation in an at-risk diabetic population: a retrospective study Authors: Merribeth Bruntz, DPM, MS* 1,2, Heather Young, MD 3,4, Robert W.
More informationRadiotherapy in soft tissue sarcomas
Radiotherapy in soft tissue sarcomas Authors Key words L. Renard, X. Geets, P. Scalliet Soft tissue sarcoma, radiotherapy Summary Surgery and postoperative radiotherapy has become a standard of care in
More informationSynovial Sarcoma of Extremities: Evaluation of Prognostic Factors and Clinical Outcomes
Med. J. Cairo Univ., Vol. 81, No. 1, December: 1093-1097, 2013 www.medicaljournalofcairouniversity.net Synovial Sarcoma of Extremities: Evaluation of Prognostic Factors and Clinical Outcomes SEHAM E. ABDELKHALEK,
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationSurgical outcome and patterns of recurrence for retroperitoneal sarcoma at a single centre
ONCOLOGY Ann R Coll Surg Engl 2016; 98: 192 197 doi 10.1308/rcsann.2016.0057 Surgical outcome and patterns of recurrence for retroperitoneal sarcoma at a single centre HDJ Hogg 1, DM Manas 1, D Lee 1,
More informationSoft Tissue Sarcoma. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee
Soft Tissue Sarcoma Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Soft Tissue Sarcoma Collective term for an unusual and diverse
More informationRadiotherapy Considerations in Extremity Sarcoma
Radiotherapy Considerations in Extremity Sarcoma Peter Chung Department of Radiation Oncology Princess Margaret Hospital University of Toronto Role of RT in STS Local tumour eradication while allowing
More informationResearch Article Improvement in Overall Survival from Extremity Soft Tissue Sarcoma over Twenty Years
Sarcoma Volume 2015, Article ID 279601, 9 pages http://dx.doi.org/10.1155/2015/279601 Research Article Improvement in Overall Survival from Extremity Soft Tissue Sarcoma over Twenty Years Andrew J. Jacobs,
More informationLocal recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project
Acta Orthopaedica Scandinavica ISSN: 0001-6470 (Print) (Online) Journal homepage: http://www.tandfonline.com/loi/iort19 Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project Clement
More informationSurvival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer
Survival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer Jayashree Kalpathy-Cramer PhD 1, William Hersh, MD 1, Jong Song Kim, PhD
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationResearch Article A Clinicopathological Analysis of Soft Tissue Sarcoma with Telangiectatic Changes
Sarcoma Volume 2015, Article ID 740571, 5 pages http://dx.doi.org/10.1155/2015/740571 Research Article A Clinicopathological Analysis of Soft Tissue Sarcoma with Telangiectatic Changes Hiroshi Kobayashi,
More information3D CONFORMATIONAL INTERSTITIAL BRACHYTHERAPY PLANNING FOR SOFT TISSUE SARCOMA
3D CONFORMATIONAL INTERSTITIAL BRACHYTHERAPY PLANNING FOR SOFT TISSUE SARCOMA Alina TĂNASE 1,3, M. DUMITRACHE 2,3, O. FLOREA 1 1 Emergency Central Military Hospital Dr. Carol Davila Bucharest, Romania,
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationMalignant Fibrous Histiocytoma: Database Review Suggests a Favorable Prognosis in the Head and Neck
The Laryngoscope VC 2017 The American Laryngological, Rhinological and Otological Society, Inc. Malignant Fibrous Histiocytoma: Database Review Suggests a Favorable Prognosis in the Head and Neck Robert
More informationDoes Using a Laparoscopic Approach to Cholecystectomy Decrease the Risk of Surgical Site Infection?
ANNALS OF SURGERY Vol. 237, No. 3, 358 362 2003 Lippincott Williams & Wilkins, Inc. Does Using a Laparoscopic Approach to Cholecystectomy Decrease the Risk of Surgical Site Infection? Chesley Richards,
More information1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor Study.
CCSS Analysis Concept Proposal Exercise, Mortality, & Childhood Cancer 1 1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor
More informationThe Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)
The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) Disclosure None Background Torino, Italy LCNC Rare tumor (2% to 3% all resected primary lung cancers) Preoperative
More informationUpdate on Sarcomas of the Head and Neck. Kevin Harrington
Update on Sarcomas of the Head and Neck Kevin Harrington Overview Classification and incidence of sarcomas Clinical presentation Challenges to treatment Management approaches Prognostic factors Radiation-induced
More informationLarge Colorectal Adenomas An Approach to Pathologic Evaluation
Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,
More informationGenetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma M.J. Wang, Y. Zhu, X.J. Guo and Z.Z. Tian Department of Orthopaedics, Xinxiang Central Hospital, Xinxiang,
More informationContents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology
Contents Part I Introduction 1 General Description... 3 1.1 Introduction... 3 1.2 Incidence and Prevalence... 5 1.3 Predisposing and Genetic Factors... 8 References... 16 2 Natural History: Importance
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationEFFECT OF AN ENHANCED RECOVERY AFTER SURGERY PROGRAM ON OPIOID USE AND PATIENT-REPORTED OUTCOMES
EFFECT OF AN ENHANCED RECOVERY AFTER SURGERY PROGRAM ON OPIOID USE AND PATIENT-REPORTED OUTCOMES Obstetrics & Gynecology Vol. 132, No. 2, August 2018 KUSMW OBGYN Journal Club Thomas Greaves, MD, PGY4 August
More informationEvaluation of prognostic scoring systems for bone metastases using single center data
MOLECULAR AND CLINICAL ONCOLOGY 3: 1361-1370, 2015 Evaluation of prognostic scoring systems for bone metastases using single center data HIROFUMI SHIMADA 1, TAKAO SETOGUCHI 2, SHUNSUKE NAKAMURA 1, MASAHIRO
More informationARTICLE IN PRESS. doi: /j.ijrobp METAPLASTIC CARCINOMA OF THE BREAST: A RETROSPECTIVE REVIEW
doi:10.1016/j.ijrobp.2005.08.024 Int. J. Radiation Oncology Biol. Phys., Vol. xx, No. x, pp. xxx, 2005 Copyright 2005 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/05/$ see front matter
More informationSoluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors
Soluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors Mikinobu Goto, MD, Akihiko Matsumine, MD,PhD, Tomoki Nakamura, MD PhD, Takao Matsubara, MD PhD, Kunihiro Asanuma, MD,PhD, Toru Oi,
More informationIntroduction. Original Article
bs_bs_banner International Journal of Urology (2015) 22, 363 367 doi: 10.1111/iju.12704 Original Article Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after
More informationLower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University
More informationThe effect of delayed adjuvant chemotherapy on relapse of triplenegative
Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationSurgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database
Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department
More informationPrognostic significance of histological invasion in high grade soft tissue sarcomas
Tsukushi et al. SpringerPlus 2014, 3:544 a SpringerOpen Journal RESEARCH Open Access Prognostic significance of histological invasion in high grade soft tissue sarcomas Satoshi Tsukushi *, Yoshihiro Nishida,
More information14. Background. Sarcoma. Resectable extremity soft tissue sarcomas
96 14. Sarcoma Background Radiotherapy is widely used as an adjunct to surgery in the management of soft tissue sarcomas as the risk of failure in the surgical bed can be high. For bone sarcomas, radiotherapy
More informationComparative study of planned and unplanned excisions for the treatment of soft tissue sarcoma of the extremities
CLINICAL SCIENCE Comparative study of planned and unplanned excisions for the treatment of soft tissue sarcoma of the extremities Carlos E. H. Hanasilo, I Marcelo S. Casadei, I Leandro Auletta, I Eliane
More informationClinical Problems After Initial Unplanned Resection of Sarcoma
Jpn J Clin Oncol 2008;38(10)701 709 doi:10.1093/jjco/hyn093 Clinical Problems After Initial Unplanned Resection of Sarcoma Manabu Hoshi 1, Makoto Ieguchi 1, Masatsugu Takami 2, Masanari Aono 3, Susumu
More informationAdvances in radiation oncology in the management of soft tissue sarcoma 放疗于治疗肉瘤的最新发展
Advances in radiation oncology in the management of soft tissue sarcoma 放疗于治疗肉瘤的最新发展 Brian O Sullivan Bartley-Smith / Wharton Chair Professor, Department of Radiation Oncology The Princess Margaret / University
More informationResearch Article Immediate versus Delayed Sarcoma Reconstruction: Impact on Outcomes
Sarcoma Volume 2016, Article ID 7972318, 5 pages http://dx.doi.org/10.1155/2016/7972318 Research Article Immediate versus Delayed Sarcoma Reconstruction: Impact on Outcomes Kyle J. Sanniec, 1 Cristine
More informationPlate Exposure after Reconstruction by Plate and Anterolateral Thigh Flap in Head and Neck Cancer Patients with composite mandibular Defects
Plate Exposure after Reconstruction by Plate and Anterolateral Thigh Flap in Head and Neck Cancer Patients with composite mandibular Defects Chia-Hsuan Tsai/ Huang-Kai Kao M. D. Introduction Malignant
More informationPeri-Operative Brachytherapy In Soft-Tissue Sarcomas. Hospital USM Experience
ISPUB.COM The Internet Journal of Oncology Volume 7 Number 2 Peri-Operative Brachytherapy In Soft-Tissue Sarcomas. Hospital USM Experience B Biswal, N Idris, Z Wan, W Ismail, A Halim Citation B Biswal,
More informationEvaluation of AJCC, UICC, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma
Evaluation of AJCC, UICC, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma Karia, et al Methods Details of data collectionfeatures of primary tumors including anatomic
More informationMalignant Peripheral Nerve Sheath Tumor post Wide Excision with Multiple Lung Metastases: the Role and Treatment Consideration of RT
Malignant Peripheral Nerve Sheath Tumor post Wide Excision with Multiple Lung Metastases: the Role and Treatment Consideration of RT Case Number: RT2009-64(M) Potential Audiences: Intent Doctor, Oncology
More informationComplex Thoracoscopic Resections for Locally Advanced Lung Cancer
Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,
More informationReconstructive treatment following resection of high-grade soft-tissue sarcomas of the lower limb
Journal of Orthopaedic Surgery 2005;13(1):58-63 Reconstructive treatment following resection of high-grade soft-tissue sarcomas of the lower limb AM Leow, AS Halim Reconstructive Sciences Department, Hospital
More informationLocalized extremity soft tissue sarcoma: towards a patient-tailored approach Stevenson, Marc Gilliam
University of Groningen Localized extremity soft tissue sarcoma: towards a patient-tailored approach Stevenson, Marc Gilliam IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationStatistics and Epidemiology Practice Questions
1. Which of the following is not considered a measure of central tendency? a. Median b. Range c. Mode d. Average 2. Given the following set of values, what is the median? 4 5 9 3 8 3 7 1 5 3 a. 3 b. 5
More informationA Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia
A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne Rheaume, Ian Fleetwood,
More informationOutcomes of Patients with Preoperative Weight Loss following Colorectal Surgery
Outcomes of Patients with Preoperative Weight Loss following Colorectal Surgery Zhobin Moghadamyeghaneh MD 1, Michael J. Stamos MD 1 1 Department of Surgery, University of California, Irvine Nothing to
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationORIGINAL ARTICLE. Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence
ORIGINAL ARTICLE Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence Michael D. Kernohan, FDSRCS, FRCS, MSc; Jonathan R. Clark, FRACS; Kan Gao, BEng; Ardalan Ebrahimi, FRACS;
More informationRadiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience
Radiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience Poster No.: RO-0003 Congress: RANZCR FRO 2012 Type: Scientific Exhibit Authors: C. Harrington,
More informationSurgical Management of Pancreatic Cancer
I Congresso de Oncologia D Or July 5-6, 2013 Surgical Management of Pancreatic Cancer Michael A. Choti, MD, MBA, FACS Department of Surgery Johns Hopkins University School of Medicine, Baltimore, MD Estimated
More informationRESEARCH ARTICLE. Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran
DOI:http://dx.doi.org/10.7314/APJCP.2016.17.1.159 RESEARCH ARTICLE Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran Mohammad Zare-Bandamiri 1, Narges Khanjani 2 *, Yunes Jahani
More informationSupplementary Online Content
Supplementary Online Content Won EJ, Lehman EB, Geletzke AK, et al. Association of postoperative hyperglycemia with outcomes among patients with complex ventral hernia repair. JAMA Surg. Published online
More informationRisk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer
HEALTH SERVICES RESEARCH FUND Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer Key Messages 1. Previous inflammation or infection of
More informationAge group No. of patients >60 15 Total 108
88 Original Article Soft Tissue Sarcoma in Uganda. A.M. Gakwaya 1, J. Jombwe 2, 1 Senior Consultant Surgeon, 2 Senior registrar, Dept. Of Surgery Mulago Hospital Complex, Kampala, Uganda Correspondence
More informationWe have studied 560 patients with osteosarcoma of a
Osteosarcoma of the limb AMPUTATION OR LIMB SALVAGE IN PATIENTS TREATED BY NEOADJUVANT CHEMOTHERAPY G. Bacci, S. Ferrari, S. Lari, M. Mercuri, D. Donati, A. Longhi, C. Forni, F. Bertoni, M. Versari, E.
More informationSurgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn Widhe, MD, and Prof. Henrik C. F. Bauer, MD, PhD
More informationThe management of myxofibrosarcoma a ten-year experience in a single specialist centre
Acta Orthop. Belg., 2014, 80, 436-441 ORIGINAL STUDY The management of myxofibrosarcoma a ten-year experience in a single specialist centre Jessica Daniels, Carl M. Green, Anthony Freemont, Ashok Paul
More informationPoor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas
10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,
More information